首页 | 本学科首页   官方微博 | 高级检索  
     

拉米夫定治疗慢性乙型肝炎的临床研究
引用本文:邹海殊,张文超,蒋广华,金宝胜,陈雁南,徐文波. 拉米夫定治疗慢性乙型肝炎的临床研究[J]. 吉林医药学院学报, 1999, 0(2)
作者姓名:邹海殊  张文超  蒋广华  金宝胜  陈雁南  徐文波
作者单位:解放军第465医院!吉林市132013(邹海殊,张文超,蒋广华,金宝胜,徐文波),吉林市中心医院!吉林市132013(陈雁南)
摘    要:笔者观察了拉米夫定治疗慢性乙型肝炎的临床疗效,并与病毒唑进行对照比较.结果表明,口服拉米夫定100mg/d,可明显抑制乙型肝炎病毒的复制,表现为HBV-DNA、HBeAg转阴及ALT下降,疗效明显优于病毒唑.

关 键 词:拉米夫定  慢性  乙型肝炎  病毒

Clinical study of treatment for chronic hepatitis B with lamivudine
Zou Haishu,Zhang Wenchao,Jiang Guanghua et al. Clinical study of treatment for chronic hepatitis B with lamivudine[J]. Journal of Jilin Medical College, 1999, 0(2)
Authors:Zou Haishu  Zhang Wenchao  Jiang Guanghua et al
Affiliation:Zou Haishu,Zhang Wenchao,Jiang Guanghua et al The 465th Hospital,PLA,Jilin City,132013
Abstract:Clinical effects of the treatment for chronic hepatitis B with lamivudine were observed and compared with the effects with virazole. The result showed that daily dose of lamivudine could restrict the replication of HBV obviously, with HBV-DNA and BHeAg turning negative and ALT declining. The curative effect of lamivudine was better than that of virazole
Keywords:lamivudine  chronic  hepatitis B  HBV
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号